Company intelligence / Profile preview

BioMed Central

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

BioMed Central is a pioneering open access (OA) publisher with a portfolio of around 300 peer-reviewed journals in science, technology, engineering, and medicine, including prominent titles such as BMC Medicine and BMC Biology. It operates as an imprint under Springer Nature after acquisitions by Springer (2008) and Holtzbrinck Publishing Group (2015), and has helped drive the OA movement and article processing charge (APC) business model in scholarly publishing[2][3][5][4][1].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Partnerships with leading academic institutions and societies to publish journals on their behalf

Beyond the preview

Go deeper on BioMed Central.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMed Central.

Explore the full profile